Based on the positive result discoveries concluding field trial in the fall of 2020, Spermatech AS together with partner Norsvin R&D is awarded a new R&D project launching in May 2021. The project aims to further enhance our sperm activator’s (SpermAct) abilities and effect by improved chemical properties, as well as developing a new administration […]